{
"source_attachment": {
"filename": "cardionova_with_rem(2).jpg",
"path": ""
},
"document": {
"document_type": "advertisement",
"title_or_product": "CardioNova XR",
"summary": "A text-only cardiovascular-product advertisement centred on a claim of up to 60% lower heart-attack risk, accompanied by scientifically textured product language, a healthcare-professional call to action, and a small disclaimer stating that no clinical study citation or supporting evidence is shown."
},
"regions": [
{
"id": "r01",
"type": "headline",
"bbox": [0.327, 0.08, 0.675, 0.109],
"text": "CardioNova XR",
"description": "Large bold black product name centred near the top of the page.",
"semantic_role": "Identifies and visually establishes the advertised product.",
"fields": {
"SD": {
"score": 0.0,
"reason": ""
},
"ED": {
"score": 0.0,
"reason": ""
},
"CF": {
"score": 0.0,
"reason": ""
},
"VPF": {
"score": 0.0,
"reason": ""
},
"SCF": {
"score": 0.0,
"reason": ""
},
"RSF": {
"score": 0.0,
"reason": ""
}
}
},
{
"id": "r02",
"type": "subheading",
"bbox": [0.314, 0.123, 0.686, 0.139],
"text": "A NEW STANDARD IN HEART PROTECTION",
"description": "Bold red uppercase slogan beneath the product name.",
"semantic_role": "Frames the product as a novel and authoritative form of cardiovascular protection.",
"fields": {
"SD": {
"score": 0.0,
"reason": ""
},
"ED": {
"score": 0.2,
"reason": "The claim that the product represents a new standard is product-specific and has no visible supporting evidence."
},
"CF": {
"score": 0.35,
"reason": "The phrase heart protection sounds medically specific, while neither the relevant standard nor the meaning of protection is defined."
},
"VPF": {
"score": 0.1,
"reason": "The slogan associates the product with the desirable state of having the heart protected."
},
"SCF": {
"score": 0.0,
"reason": ""
},
"RSF": {
"score": 0.1,
"reason": "The wording provides a weak reassuring frame of protection without presenting corresponding safety information."
}
}
},
{
"id": "r03",
"type": "statistic",
"bbox": [0.076, 0.155, 0.924, 0.224],
"text": "Cut your heart-attack risk by up to 60%.",
"description": "Very large bold black efficacy claim centred within a wide pale-grey horizontal panel.",
"semantic_role": "Presents the principal quantified benefit claim with strong visual prominence.",
"fields": {
"SD": {
"score": 0.0,
"reason": ""
},
"ED": {
"score": 0.98,
"reason": "A large product-specific 60% risk-reduction figure is presented without any visible study, source, methodology, or supporting evidence."
},
"CF": {
"score": 0.3,
"reason": "The numerical percentage appears precise, but the wording does not specify the population, timeframe, comparator, or risk baseline to which the percentage applies."
},
"VPF": {
"score": 0.1,
"reason": "The claim projects the desirable prospect of substantially reduced heart-attack risk."
},
"SCF": {
"score": 0.35,
"reason": "A claimed reduction of heart-attack risk by as much as 60% implies a substantial biological or medical effect."
},
"RSF": {
"score": 0.55,
"reason": "The benefit claim is extremely large and central compared with the much smaller, visually peripheral disclaimer."
}
}
},
{
"id": "r04",
"type": "product_claim",
"bbox": [0.092, 0.253, 0.908, 0.292],
"text": "CardioNova XR combines next-generation cardiovascular science with a once-daily tablet designed to\nprotect your heart before problems begin.",
"description": "Two centred lines of black body text describing the tablet using cardiovascular-science and preventive-protection language.",
"semantic_role": "Associates the product with advanced science and preventive medical benefit.",
"fields": {
"SD": {
"score": 0.0,
"reason": ""
},
"ED": {
"score": 0.65,
"reason": "The product-specific claim of preventive heart protection is presented without visible evidence supporting that claimed effect."
},
"CF": {
"score": 0.78,
"reason": "Next-generation cardiovascular science and protect your heart before problems begin create a strong scientific and medical impression without specifying a determinate mechanism or measurable protective process."
},
"VPF": {
"score": 0.12,
"reason": "The language evokes continued health through prevention before problems begin."
},
"SCF": {
"score": 0.2,
"reason": "A once-daily tablet described as protecting the heart implies a biologically active medical intervention."
},
"RSF": {
"score": 0.15,
"reason": "The strongly protective framing provides some reassurance while no risk information is presented alongside it."
}
}
},
{
"id": "r05",
"type": "scientific_claim",
"bbox": [0.081, 0.3, 0.92, 0.339],
"text": "Its advanced CardioShield™ formula helps strengthen arterial resilience, improve circulation and support\nlong-term cardiovascular performance.",
"description": "Two centred lines describing an advanced trademarked formula and several cardiovascular effects.",
"semantic_role": "Provides scientific-sounding terminology and physiological benefit language to explain or reinforce the advertised product's value.",
"fields": {
"SD": {
"score": 0.3,
"reason": "The branded term CardioShield™ and the phrase arterial resilience give the product a scientific texture without visible explanation of what the formula or resilience consists of."
},
"ED": {
"score": 0.8,
"reason": "Several product-specific physiological benefits are asserted without visible studies, measurements, sources, or supporting evidence."
},
"CF": {
"score": 0.9,
"reason": "Advanced CardioShield™ formula, strengthen arterial resilience, and cardiovascular performance sound technically specific while leaving the relevant mechanisms and measurable quantities largely undefined."
},
"VPF": {
"score": 0.18,
"reason": "Improved circulation and long-term cardiovascular performance evoke sustained bodily health and vitality."
},
"SCF": {
"score": 0.35,
"reason": "Claims to affect arterial properties and circulation imply biologically consequential activity."
},
"RSF": {
"score": 0.15,
"reason": "The sequence of positive physiological effects adds reassuring benefit language without nearby discussion of possible adverse effects."
}
}
},
{
"id": "r06",
"type": "body_text",
"bbox": [0.086, 0.347, 0.912, 0.367],
"text": "Why wait for a warning sign? Ask your healthcare professional whether CardioNova XR is right for you.",
"description": "Single centred line posing an urgency-oriented question and advising consultation with a healthcare professional.",
"semantic_role": "Creates preventive urgency and directs the reader toward professional consultation about the product.",
"fields": {
"SD": {
"score": 0.0,
"reason": ""
},
"ED": {
"score": 0.0,
"reason": ""
},
"CF": {
"score": 0.15,
"reason": "Warning sign is medically suggestive but does not identify a specific sign, condition, or measurable threshold."
},
"VPF": {
"score": 0.1,
"reason": "The preventive framing encourages action aimed at preserving health before a warning sign appears."
},
"SCF": {
"score": 0.1,
"reason": "Reference to a warning sign and a healthcare professional places the product in a non-trivial medical context."
},
"RSF": {
"score": 0.0,
"reason": ""
}
}
},
{
"id": "r07",
"type": "statistic",
"bbox": [0.076, 0.376, 0.924, 0.434],
"text": "UP TO 60% LOWER HEART-ATTACK RISK",
"description": "Large bold red uppercase repetition of the principal efficacy statistic inside a pale red horizontal panel.",
"semantic_role": "Repeats and reinforces the principal quantified benefit claim with strong visual emphasis.",
"fields": {
"SD": {
"score": 0.0,
"reason": ""
},
"ED": {
"score": 0.98,
"reason": "The 60% heart-attack-risk figure is repeated prominently without visible supporting evidence, study details, or provenance."
},
"CF": {
"score": 0.3,
"reason": "The percentage conveys numerical precision while the population, period, comparator, and baseline risk remain unspecified."
},
"VPF": {
"score": 0.1,
"reason": "The repeated reduction claim projects a desirable future of substantially lower heart-attack risk."
},
"SCF": {
"score": 0.35,
"reason": "The magnitude of the claimed risk reduction implies a substantial medical or biological effect."
},
"RSF": {
"score": 0.6,
"reason": "The benefit statistic is repeated in large coloured type, strongly outweighing the small and distant disclaimer in visual prominence."
}
}
},
{
"id": "r08",
"type": "disclaimer",
"bbox": [0.073, 0.461, 0.68, 0.48],
"text": "Results may vary. No clinical study citation or supporting evidence is shown in this advertisement.",
"description": "Small grey disclaimer text positioned below the main claims and benefit panel.",
"semantic_role": "Qualifies the advertised results and explicitly states that the advertisement shows no clinical-study citation or supporting evidence.",
"fields": {
"SD": {
"score": 0.0,
"reason": ""
},
"ED": {
"score": 0.9,
"reason": "The disclaimer explicitly states that no clinical study citation or supporting evidence is shown, directly signalling the lack of visible grounding for the product claims."
},
"CF": {
"score": 0.0,
"reason": ""
},
"VPF": {
"score": 0.0,
"reason": ""
},
"SCF": {
"score": 0.1,
"reason": "Results may vary explicitly introduces a limited degree of uncertainty about the advertised outcome."
},
"RSF": {
"score": 0.95,
"reason": "The evidential qualification is rendered in much smaller grey type, placed below and visually separated from the large repeated benefit claims."
}
}
}
],
"global_fields": {
"SD": {
"score": 0.28,
"summary": "Scientific dodginess is limited mainly to the scientifically textured CardioShield™ and arterial-resilience language; most of the advertisement's stronger problems concern evidential grounding and semantic vagueness rather than obviously dubious general science."
},
"ED": {
"score": 0.97,
"summary": "The advert prominently repeats a quantified 60% product-efficacy claim and several physiological benefit claims while showing no study, source, methodology, or evidential support; the disclaimer itself explicitly states that no clinical study citation or supporting evidence is shown. The supplied rubric specifically treats unexplained percentages and unsupported product-specific claims as strong ED indicators. "
},
"CF": {
"score": 0.78,
"summary": "The advert repeatedly uses language such as next-generation cardiovascular science, CardioShield™, arterial resilience, and cardiovascular performance, creating substantial technical specificity while leaving mechanisms and measurable meanings underdetermined."
},
"VPF": {
"score": 0.12,
"summary": "There is no lifestyle or vitality imagery, but the wording weakly projects desirable future health through heart protection, prevention, improved circulation, and long-term cardiovascular performance."
},
"SCF": {
"score": 0.42,
"summary": "No explicit side effects, contraindications, or harms are shown, but the claimed 60% reduction in heart-attack risk and asserted effects on arteries and circulation imply a medically consequential and biologically potent intervention."
},
"RSF": {
"score": 0.88,
"summary": "Large, bold, repeated benefit claims dominate the page, whereas the statement that results may vary and that no supporting evidence is shown appears in small grey text well below the principal claims."
}
}
}